Ion Cotarla
4PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 23, 2025
Utilization of extended-interval, fixed-dosing of durvalumab, every 4 weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation.Reina Haque, Eric McGary, Mike Z Yang
|Jun 19, 2023
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.Amanda M Moore, Zohra Nooruddin, Kelly R Reveles
|Jan 24, 2022
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment.Candice Yong, M Janelle Cambron-Mellott, Brian Seal
|Jun 20, 2020
Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.Ion Cotarla, Marnie L Boron, Shawna L Cullen
Pageof 1
Frequent Collaborators
1 joint publications
Marnie L Boron
1 joint publications
Surbhi Shah
1 joint publications
Adam Yagui-Beltran
1 joint publications
Candice Yong
1 joint publications
M Janelle Cambron-Mellott
1 joint publications
Brian Seal
1 joint publications
Oliver Will
1 joint publications
Martine C Maculaitis
1 joint publications
Ranee Mehra
1 joint publications
Amanda M Moore
